Brain-Derived Neurotrophic Factor Mediates the Activity-Dependent Regulation of Inhibition in Neocortical Cultures (original) (raw)

Articles

Journal of Neuroscience 15 June 1997, 17 (12) 4527-4535; https://doi.org/10.1523/JNEUROSCI.17-12-04527.1997

Loading

Abstract

The excitability of cortical circuits is modulated by interneurons that release the inhibitory neurotransmitter GABA. In primate and rodent visual cortex, activity deprivation leads to a decrease in the expression of GABA. This suggests that activity is able to adjust the strength of cortical inhibition, but this has not been demonstrated directly. In addition, the nature of the signal linking activity to GABA expression has not been determined. Activity is known to regulate the expression of the neurotrophin brain-derived neurotrophic factor (BDNF), and BDNF has been shown to influence the phenotype of GABAergic interneurons. We use a culture system from postnatal rat visual cortex to test the hypothesis that activity is regulating the strength of cortical inhibition through the regulation of BDNF. Cultures were double-labeled against GABA and the neuronal marker MAP2, and the percentage of neurons that were GABA-positive was determined. Blocking spontaneous activity in these cultures reversibly decreased the number of GABA-positive neurons without affecting neuronal survival. Voltage-clamp analysis of inhibitory currents demonstrated that activity blockade also decreased GABA-mediated inhibition onto pyramidal neurons and raised pyramidal neuron firing rates. All of these effects were prevented by incubation with BDNF during activity blockade, but not by neurotrophin 3 or nerve growth factor. Additionally, blockade of neurotrophin signaling mimicked the effects of activity blockade on GABA expression. These data suggest that activity regulates cortical inhibition through a BDNF-dependent mechanism and that this neurotrophin plays an important role in the control of cortical excitability.

Maintaining the correct balance of excitation and inhibition is crucial for the proper functioning of cortical circuits (Kriegstein et al., 1987; Chagnac-Amitai et al., 1989), suggesting that this balance should be tightly regulated both during development and in adulthood. The excitability of cortical circuits is modulated by interneurons that release the inhibitory neurotransmitter GABA. In primate and rodent visual cortex, expression of GABA is influenced by visual input; dark-rearing or TTX injection into one eye decreases the number of GABA-immunopositive neurons in primary visual cortex (Hendry and Jones, 1986; Benevento et al., 1995). This suggests that activity is able to adjust the strength of cortical inhibition, but this has not been demonstrated directly.

What is the signal linking activity to the regulation of cortical GABA expression? An interesting candidate for this signal is the neurotrophin brain-derived neurotrophic factor (BDNF). The neurotrophins are a class of factors, including BDNF, nerve growth factor (NGF), and neurotrophin 3 (NT3), that support the survival and differentiation of a variety of peripheral and central neurons (for review, see Lindsay et al., 1994). BDNF expression in postnatal cortex is tightly regulated by neuronal activity. Seizure induction in vivo or depolarization by high potassium in culture increase cortical BDNF expression (Isackson et al., 1991; Ghosh et al., 1994). There is a sharp increase in BDNF expression in visual cortex after eye opening (Maisonpierre et al., 1990), and dark-rearing decreases BDNF expression in rat visual cortex both during development and in adulthood (Castrén et al., 1992). A role for BDNF has now been suggested in a number of cortical processes (Ghosh et al., 1994;Cabelli et al., 1995; McAllister et al., 1995, 1996). BDNF can increase the GABA content and level of GAD activity in GABAergic neostriatal neurons in culture (Mizuno et al., 1994; Ventimiglia et al., 1995), influence peptide expression in hippocampal interneurons (Marty et al., 1996a,b), and increase GABA uptake and soma size in embryonic cortical interneurons (Widmer and Hefti, 1994). These studies suggest that BDNF can influence transmitter expression in several populations of central interneurons.

These observations raise the possibility that activity regulates inhibition in visual cortical circuits through the regulation of BDNF. We use a postnatal culture system from rat visual cortex, containing both excitatory pyramidal neurons and inhibitory interneurons, to test this hypothesis. We show that blockade of spontaneous activity reversibly decreases the number of neurons that are immunopositive for GABA. This decrease in GABA expression is correlated with a decrease in inhibition between interneurons and pyramidal neurons and an increase in pyramidal neuron firing rates. These effects of activity blockade can be prevented by BDNF, but not by NGF or NT3, and blockade of neurotrophin receptor signaling with K252a mimics the effects of activity blockade. These data suggest that activity continuously adjusts cortical inhibition and pyramidal neuron firing rates by regulating the production of BDNF.

MATERIALS AND METHODS

Cell cultures

Cultures from postnatal rat visual cortex were prepared using a modification of the technique of Huettner and Baughman (1986, 1988). Rat pups between postnatal days 4 and 6 were anesthetized using isofluorane and decapitated. The brain was removed, and a portion of occipital cortex corresponding to visual cortex was removed and placed into sterile artificial cerebral spinal fluid (ACSF) containing (in mm): 126 NaCl, 3 KCl, 2 CaCl2, 2 MgSO4, 1 NaHPO4, and 25 NaHCO3, equilibrated with 5% CO2/95% O2). The tissue was minced and the ACSF was withdrawn, and enzyme solution composed of 25 U/ml papain, 1 mml-cystein, and 0.5 mm EDTA (Worthington Biochemical, Freehold, NJ) in Earle’s balanced salt solution (EBSS, Life Technologies, Gaithersburg, MD) was added and the tissue was incubated for 1.5 hr in a 5% CO2incubator at 37°C. The tissue was rinsed in a weak trypsin inhibitor solution (1 mg/ml ovomucoid and 1 mg/ml BSA in sterile EBSS) and gently triturated, and a strong inhibitor solution (10 mg/ml ovomucoid and 10 mg/ml BSA in sterile EBSS) was added and the suspension centrifuged at low speed for 5 min. The supernatant was withdrawn, and the pellet was resuspended in 5 ml of growth medium (see below) and plated at a density of ∼100,000 cells/cm2 onto glass-bottom 35 mm culture dishes previously coated with rat tail collagen. Growth medium consisted of MEM (Life Technologies) with 5% fetal bovine serum, 1% N2 supplement (Life Technologies), 30 mm dextrose, 200 mml-glutamine, and 50 U/ml penicillin/streptomycin, with a final osmolarity between 310 and 320 mOsM. Cultures were incubated in a 5% CO2 incubator at 37°C until use. Cultures were fed every 3–4 d by replacing 1 ml of medium with fresh medium. After 3–5 d in vitro, when non-neuronal cells became confluent, cell proliferation was inhibited by adding 10 μm 1-gamma-d-arabinofuranosyl cytosine.

Electrophysiology

Current-clamp recordings. For electrophysiological recordings, cultures were moved to the stage of an inverted Nikon Diphot microscope and superfused continuously with ACSF + 20 mm dextrose at room temperature, with an osmolarity of 305–310 mOsM. The ACSF was bubbled continuously with 5% CO2/95% O2. The preparation was grounded with a silver/silver chloride ground wire connected to the headstage of an Axoclamp 2B. Whole-cell recordings were obtained using patch pipettes (3–5 MΩ resistances) filled with intracellular solution consisting of (in mm): 130 KMeSO4, 10 KCl, 10 K-HEPES, 2 MgSO4, 0.5 EGTA, and 3 ATP; final osmolarity was adjusted to 290–295 mOsM with sucrose. Seal resistances were 3–6 GΩ, and series resistances were 5–15 MΩ and were left uncompensated. The amplifier was controlled, and data were acquired using the Pulse Control software (J. Herrington, K. Newton, and R. Bookman, University of Miami) running on a PowerMac 7100 interfaced with the amplifier using an ITC 16 board (Instrutech, Great Neck, NY). Neurons with resting potentials of less than −50 mV, input resistances of <700 MΩ, or recordings with series resistances >20 MΩ were discarded. For recording purposes, bipolar interneurons were identified morphologically, based on a distinctive oval shape to the soma with two prominent dendrites emerging from the long axes (see Fig.2D).

Fig. 2.

Fig. 2.

GABA immunoreactivity in cortical cultures.A, MAP2-positive neurons from cortical cultures after 7 d in vitro, viewed with fluorescein filters.B, Same field of view as in A, using rhodamine filters to show GABA-positive neurons. C, GABA-positive multipolar neuron. D, GABA-positive bipolar neuron. Scale bars: A, B, 10 μm; C, D, 25 μm.

Voltage-clamp recordings. Synaptic currents were recorded as described above, except that the amplifier used was an Axopatch 1B in voltage-clamp mode, and the internal solution contained 130 mm CeMeSO4 in place of KMeSO4 to block potassium currents, 10 mm EGTA, and 10 mmQX-314 to block generation of action potentials. This allowed neurons to be voltage-clamped to 0 mV (the reversal potential of the excitatory currents) so that large, outward GABA-mediated currents could be recorded in isolation. Each neuron was voltage-clamped to −70 mV and then stepped up to 0 mV for 30 sec recording periods interspersed with 30 sec rest periods at −70 mV. Four minutes of data was obtained and averaged for each neuron. For each recording, series resistance and input resistance were continuously monitored, and if these values changes by >15%, the data were discarded, as were recordings with series resistances of >20 MΩ.

Immunohistochemistry

Cultures were processed for indirect immunofluorescence against GABA and the neuronal marker MAP2. Cultures were fixed for 10 min using a 4% paraformaldehyde, 5% sucrose solution in 0.2 mphosphate buffer. Cultures were washed three times in PBS (137 mm NaCl, 3 mm KCl, in 0.2 mphosphate buffer). They were then blocked and permeabilized in 10% goat serum and 0.1% Triton X-100 in PBS for 20 min. The cultures were then incubated overnight in primary antibody in 10% goat serum in PBS (PBS-G). Cultures were rinsed three times with PBS and washed for 1 hr in PBS-G. The cultures were incubated in the secondary antibodies in PBS-G for 1 hr at room temperature, then washed for 2 hr in PBS, serially dehydrated in ethanol, and rinsed two times in xylene. They were mounted in DPX (Electron Microscopy Sciences, Fort Washington, PA) and coverslipped and allowed to dry before examination.

To double-label cultures against both GABA and MAP2, cultures were incubated concurrently in a rabbit anti-GABA polyclonal antiserum (Sigma, 1:800) and a mouse monoclonal anti-MAP2 antibody (Sigma, 1:500). Secondary antibodies were a rhodamine-conjugated goat anti-rabbit and a fluorescein-conjugated goat anti-mouse (Boehringer-Mannheim, Indianapolis, IN, both used at concentrations of 1:50). Preabsorption of the anti-GABA antiserum for 4 hr with 10−4 M GABA completely abolished staining, whereas staining was unaffected by preabsorption with 10−4 M glutamate. No staining was observed when the primary antibodies were omitted from the protocol. Cultures were photographed using a laser scanning Bio-Rad MRC 600 Confocal microscope (Hercules, CA) equipped with rhodamine and fluorescein optics.

Cell counts and physiological data analysis

Cultures were examined and counted using a Nikon Diphot inverted microscope equipped with fluorescence optics. Cell counts were accomplished by counting the number of immunostained neurons in consecutive fields of view in two independent strips through the center of each dish. Results for the two strips were then averaged. Each field of view was counted first for the total number of MAP2-positive neurons using fluorescein filters and then for the total number of GABA-positive neurons using rhodamine filters. For each dish, the number of GABA-positive neurons/strip was divided by the total number of neurons/strip to give the percent of GABA-positive neurons for each dish. Only dishes in which there were >100 neurons/strip were included, although results for less dense cultures were not significantly different. Among the dishes with >100 neurons/strip, neuronal densities did not vary significantly among conditions and averaged 62 ± 12 neurons/mm2. All numbers are expressed as the mean ± SEM for the number of cultures (for cell counts) or the number of neurons (for physiological recordings) indicated. Each manipulation was tested on cultures from at least two different platings. For each experiment, controls from sister cultures were run in parallel. To analyze spike frequency data, the number of spontaneous action potentials generated in a 4 min period was measured, and this number was then expressed as spikes/min. To accurately measure resting potentials and input resistances, these values were measured with synaptic transmission blocked with the AMPA receptor antagonist CNQX (50 μm) and the GABAA receptor antagonist bicuculline (10 μm). To analyze synaptic current data, the total area under the outward current transients was integrated for each 30 sec sweep of data. This value was averaged over eight such 30 sec sweeps to give a measure of the outward current per unit time for each neuron.

For wash experiments, cultures were treated with TTX for 2 d, and the TTX was then washed out through seven exchanges of 1 ml of medium with fresh control medium. Control cultures were washed identically to experimental cultures and fixed and processed in parallel. A stock solution of TTX (Sigma) was made in sterile H2O and kept at 4°C; 2 μl was added to each treated culture for a final concentration of 0.1 μm. TTX was refreshed after 24 hr. For some control cultures, vehicle was added at the same concentration and had no effect on GABA staining. Human recombinant BDNF, NGF, and NT3 were obtained from the following sources: BDNF, from Promega, Hercules, CA; NGF, from Upstate Biotechnology (Lake Placid, NY); and NT3, from Amgen (Thousand Oaks, CA). Aliquots of stock solutions of BDNF, NGF, and NT3 in 1 mg/ml BSA were kept at −80°C until use, then thawed and added to the cultures at the indicated concentration. Neurotrophins were not refreshed on subsequent days. K252a was added at concentrations of 10, 50, or 200 nm and was refreshed after 24 hr.

RESULTS

Activity blockade reduces the percentage of GABA-positive neurons in cortical cultures

Cortical cultures were plated between postnatal days 4 and 6 and were maintained in culture for 1–2 weeks before experimentation. During this time, the neurons adhered to the substrate, extended processes, and formed synaptic connections. Whole-cell recordings showed that by 5 d in vitro, spontaneous synaptic potentials could be detected (Fig. 1A,arrow), which periodically brought the neurons over threshold for firing action potentials. This activity was completely blocked by the sodium channel antagonist TTX (0.1 μm) (Fig. 1B).

Fig. 1.

Fig. 1.

Spontaneous activity of cortical neurons in culture. A, Control, A whole-cell recording from a cortical pyramidal neuron after 5 d in vitro. Depolarizing synaptic potentials (arrow) could be detected, which periodically brought the neuron over threshold to fire overshooting action potentials. B, This activity was completely abolished by addition of 0.1 μm TTX to the perfusate.

We wished to know whether the number of GABA-positive neurons in these cultures is influenced by spontaneous activity. The percentage of neurons in culture that were GABA-positive was determined by double-labeling cultures against both the neuronal marker MAP2 and GABA (Fig. 2A,B). All GABA-positive neurons were MAP2-positive. The GABA-positive neurons had a variety of morphologies, including bipolar and multipolar, associated with GABAergic interneurons in vivo (Fig.2C,D). In control cultures, 29.6 ± 1.0% of the neurons were found to be GABA-positive (n = 26). This percentage is within the range reported for visual cortex of primate, rat, and cat (Gabbott and Somogyi, 1986; Hendry and Jones, 1986; Benevento et al., 1995) and in dissociated cortical cultures (Alho et al., 1988; Gotz and Boltz, 1994). Between 7 and 14 d_in vitro_, there was no significant effect of time in culture on the percentage of GABA-positive neurons; therefore, data from these ages were combined.

Treatment of cultures for 2 d with TTX reduced the percentage of GABA-positive neurons to 19.2 ± 0.9%. This represents a decrease to 64.9 ± 3.0% of control values (Fig.3A, TTX) (_n_= 14, TTX significantly different from control, Student’s _t_test, p < 0.01). This effect is similar in magnitude to the effect of visual deprivation on the number of GABA-positive neurons in rat and primate visual cortex (a reduction to ∼70% of control values) (Hendry and Jones, 1986; Benevento et al., 1995). There was no effect of TTX treatment on neuronal survival (Table1). Measurement of input resistances and resting membrane potentials of bipolar interneurons (a subset of interneurons that can be readily morphologically identified) revealed no effect of TTX treatment on these parameters (Table 2). Control experiments showed that TTX completely blocked spike generation for the duration of the treatment (data not shown).

Fig. 3.

Fig. 3.

The effects of activity blockade and neurotrophins on the percentage of GABA-positive neurons in cortical cultures.A, Cultures were treated with 0.1 μm TTX, either alone (TTX) or in the presence of 25 ng/ml BDNF (TTX + BDNF), 50 ng/ml NGF (TTX + NGF), or 25 ng/ml NT3 (TTX + NT3) for 2 d; *significantly different from control, p< 0.01. B, The effects of different doses of BDNF on the ability of TTX to reduce the percentage of GABA-positive neurons were determined. TTX (0.1 μm) was applied in the presence of the indicated concentration of BDNF for 2 d and the percentage of GABA-positive neurons determined. For each condition in_A_ and B, the ratio of GABA-positive to GABA-negative neurons was determined, and these values are expressed as a percent of the values obtained for control cultures (control = 100%, dashed line).

Table 1.

Effects of culture conditions on neuronal survival

Table 2.

Electrical properties of cortical neurons in culture

BDNF prevents the activity-dependent reduction in the number of GABA-positive neurons

BDNF levels in visual cortex can be rapidly modulated by activity (Castrén et al., 1992) and can regulate the phenotype of GABAergic interneurons in hippocampus, mesencephalon, striatum, and cortex (Hyman et al., 1994; Mizuno et al., 1994; Marty et al., 1996a,b). This suggests that visual input may regulate cortical GABA expression through the activity-dependent regulation of BDNF. If the reduction in the number of GABA-positive neurons in our visual cortical cultures produced by activity blockade is the consequence of reduced endogenous production of BDNF, then exogenous BDNF should prevent this reduction. We tested this possibility by applying TTX for 2 d in the presence of 25 ng/ml BDNF. Under these conditions, there was no reduction in the percentage of GABA-positive neurons over control values (Fig. 3A, TTX + BDNF) (n = 8). TTX + BDNF was significantly different from TTX alone (p < 0.01, Student’s _t_test) and was not different from control. BDNF significantly reduced the effects of TTX on GABA levels at concentrations as low as 1 ng/ml (the lowest concentration tested) and was saturating at concentrations between 5 and 10 ng/ml (Fig. 3B). Interestingly, when BDNF (25 ng/ml) was applied for 2 d in the presence of spontaneous activity, there was no effect on the percentage of GABA-positive neurons (Fig. 3A, BDNF) (_n_= 9).

Like BDNF, NT3 is expressed in visual cortex during prenatal and early postnatal development, but levels peak at approximately P0 and then decrease steadily, whereas BDNF levels increase steadily during the first three postnatal weeks (Maisonpierre et al., 1990; Schoups et al., 1995). NGF and its receptor TrkA are present only at very low levels in cortex (Maisonpierre et al., 1990; Allendoerfer et al., 1994; Schoups et al., 1995). Neither NGF nor NT3 was effective at preventing the reduction in GABA produced by TTX. Incubation for 2 d with TTX and 50 ng/ml NGF reduced the percentage of GABA-positive neurons to 68.2 ± 3.4% of control values (Fig. 3A, TTX + NGF) (n = 6). Incubation with TTX and 25 ng/ml NT3 produced a similar reduction, to 71.6 ± 1.6% of control values (Fig. 3A, TTX + NT3) (n = 5). These treatments were not significantly different from TTX alone. None of these manipulations significantly influenced neuronal survival (Table 1).

Blockade of neurotrophin receptor signaling reduces the number of GABA-positive neurons

The above data suggest that activity blockade is reducing the percentage of GABA-positive neurons in culture by reducing the production of BDNF. This raised the question of whether blocking the action of endogenous neurotrophins might influence the expression of GABA in these cortical cultures. The neurotrophins act through the Trk tyrosine kinase receptors TrkA (NGF), TrkB (BDNF), and TrkC (NT3) (for review, see Heumann, 1994). This family of receptors is blocked by the compound K252a, which prevents autophosphorylation of the tyrosine kinase domain of the receptors. At concentrations of 200 nmor less, K252a is a specific inhibitor of Trk receptors and blocks TrkA, TrkB, and TrkC with approximately equal efficacy, but leaving other tyrosine kinase signaling pathways, as well as protein kinase C pathways, intact (Kiozumi et al., 1988; Berg et al., 1992; Nye et al., 1992; Tapley et al., 1992).

To test whether endogenous neurotrophin signaling influences GABA expression, cultures were incubated for 2 d with various concentrations of K252a. Concentrations of K252a as low as 10 nm produced a decrease in the percentage of GABA-positive neurons (n = 3), and at concentrations of 50 nm and above, K252a significantly reduced the percentage of GABA-positive neurons to 65.3 ± 1.8 and 62.1 ± 3.4% of control, respectively (Fig. 4). The reduction produced by 50 nm (n = 3) and 200 nm(n = 9) K252a was comparable with that produced by blockade of activity with TTX (see Fig. 3A). In the presence of 200 nm K252a, BDNF did not prevent the TTX-induced reduction in the percentage of GABA-positive neurons (Fig. 4, TTX + BDNF + K252a) (n = 3), indicating that K252a was effectively blocking Trk receptor signaling at this concentration. K252a treatment had no influence on neuronal survival at any of the concentrations tested (Table 1). These data suggest that endogenous neurotrophin signaling through Trk receptors is regulating GABA expression in cortical interneurons. These data do not allow us to distinguish between signaling through the different Trk receptors, but given that neither NT3 nor NGF has any effect on GABA expression in this system, the most likely possibility is that this effect is mediated by endogenous release of BDNF.

Fig. 4.

Fig. 4.

The effects of Trk receptor blockade on the percentage of GABA-positive neurons. K252a, a blocker of Trk receptor signaling, was applied for 2 d at the indicated concentration (10, 50, or 200 nm) and the percentage of GABA-positive neurons determined. The effect of BDNF (25 ng/ml) and TTX (0.1 μm) in the presence of K252a (200 nm) for 2 d was also determined (TTX+BDNF+K252a). Numbers are expressed as a percentage of the value obtained for control cultures (control = 100%,dashed line); *significantly different from control,p < 0.05; **significantly different from control,p < 0.001.

The activity-dependent reduction in the number of GABA-positive neurons is reversible

Studies on the role of visual input and neuronal activity on GABA expression in visual cortex have suggested that decreased activity acts to lower GABA levels in surviving neurons, rather than to decrease interneuronal survival (Hendry and Jones, 1986; Benson et al., 1991). These studies have suggested a model in which activity can continuously modulate the amount of GABA produced by cortical interneurons. This model predicts that the activity-dependent reduction in the number of GABA-positive neurons in visual cortex should be reversible on reinstatement of activity, but this has not been tested.

To address this issue, activity was blocked for 2 d with TTX, then TTX was washed out and the cultures incubated for two additional days in normal medium. Control cultures were washed similarly and fixed and processed in parallel. Control experiments indicated that 2 d after TTX washout, spike generation was normal (data not shown). GABA levels were partially restored 2 d after TTX washout, to 82.7 ± 3.0% of control values (Fig. 5) (n = 6, wash significantly different from TTX alone, p < 0.05, Student’s t test). When BDNF (25 ng/ml) was added immediately after TTX washout, GABA levels were completely restored to control levels after 2 d (106.0 ± 8.7% of control,n = 3) (Fig. 5). These data indicate that the reduction in the percentage of GABA-positive neurons produced by activity blockade is fully reversible and that the degree of reversal can be influenced by exogenous BDNF.

Fig. 5.

Fig. 5.

The activity-dependent reduction in the percentage of GABA-positive neurons is reversible. Cultures were treated with TTX (0.1 μm) for 2 d. Cultures were then fixed, processed, and counted immediately (TTX); washed for 2 d before fixation (TTX/WASH); or washed and BDNF (25 ng/ml) added for 2 d before fixation. Numbers are expressed as a percentage of the value obtained for control cultures (control = 100%, dashed line); *significantly different from control, p < 0.05; **significantly different from control, p < 0.01.

Activity blockade reduces inhibition onto cortical pyramidal neurons

Although decreased activity is known to decrease the number of GABA-immunopositive neurons in visual cortex (Hendry and Jones, 1986;Benevento et al., 1995), it is unclear whether this translates into a functional reduction in inhibition. To address this issue, we asked whether chronic TTX treatment decreases the magnitude or frequency of spontaneous inhibitory currents received by pyramidal neurons. Cultures were treated for 2 d with TTX, and the TTX was then washed out for at least 30 min before recording. The blockade of spiking by TTX was fully reversible (see below). To measure IPSCs in isolation, pyramidal neurons were voltage-clamped at 0 mV (where glutamate-mediated currents reverse), allowing us to record large outward IPSCs that could be blocked by bicuculline (data not shown). Pretreatment with TTX for 2 d dramatically reduced the frequency of these spontaneous IPSCs to ∼20% of control levels (Fig.6A,B) (n = 8 neurons in each condition). To measure the total amount of inhibitory current per unit time under the different conditions, the area under the outward current transients was integrated over 30 sec time periods, and these values were averaged over 4 min of data for each neuron. Pretreatment with TTX produced a reduction in total inhibitory current to ∼36% of control values (Fig. 6A,C). Both this reduction in magnitude and the reduction in frequency of inhibitory currents were blocked by co-application of 25 ng/ml BDNF (Fig. 6) (_n_= 8 neurons). There were no significant differences in series resistance among recordings under the different conditions (control = 8.1 ± 0.5 MΩ; TTX = 7.3 ± 0.6 MΩ; and TTX + BDNF = 7.9 ± 1.6 MΩ).

Fig. 6.

Fig. 6.

Activity blockade reduces inhibition onto pyramidal neurons. A, Representative voltage-clamp recordings of spontaneous IPSCs from pyramidal neurons grown in control medium (CONTROL) in medium supplemented with 0.1 μm TTX for 2 d (TTX) or in medium supplemented with TTX and BDNF (25 ng/ml) for 2 d.B, Frequency of spontaneous IPSCs from pyramidal neurons grown under the conditions indicated in A(n = 8 neurons in each condition).C, Total inhibitory current integrated over time, from the same population as in B; *significantly different from control (Student’s t test, p< 0.04); **p < 0.01.

Activity blockade increases pyramidal neuron firing rates

Electrophysiological recordings from visual cortex of dark-reared rats show an increase in spontaneous activity relative to control animals that correlate with decreases in the number of GABA-positive neurons (Benevento et al., 1995). We asked whether the reduction in inhibition onto pyramidal neurons produced by activity blockade in our cortical cultures was correlated with an increase in pyramidal neuron firing rates. Whole-cell recordings were obtained from pyramidal neurons from control cultures or from cultures treated for 2 d with TTX after at least 0.5 hr washout of the TTX. TTX treatment was found to increase pyramidal neuron firing rates by more than an order of magnitude, from 1.6 ± 0.3 spikes/min (n = 29) to 16.5 ± 3.5 spikes/min (Fig. 7) (n = 23). Co-incubation with TTX and BDNF (25 ng/ml), which prevents the reduction in inhibition, also prevents the increase in pyramidal neuron firing rates (spike frequency was 1.4 ± 0.5,n = 13). In contrast, NT3 and NGF, which do not prevent the reduction in the number of GABA-positive neurons, also do not prevent the increase in pyramidal neuron firing rates (Fig. 7) (n = 14 and 11, respectively). No differences were found in input resistances or resting membrane potentials from neurons grown under the different experimental conditions (Table 2). These data indicate that activity can regulate pyramidal neuron firing rates and suggest that one mechanism of this regulation is the BDNF-dependent modulation of inhibition.

Fig. 7.

Fig. 7.

Activity blockade increases pyramidal neuron firing rates. A, Representative current-clamp recordings of spontaneous firing from pyramidal neurons grown in control medium (CONTROL), in medium supplemented with 0.1 μm TTX for 2 d (TTX), or in medium supplemented with TTX and BDNF (25 ng/ml) for 2 d (TTX + BDNF). B, Average spike frequency of pyramidal neurons grown for 2 d under the conditions described in_A_ or in TTX + 50 ng/ml NGF (TTX + NGF) or TTX + 25 ng/ml NT3 (TTX + NT3); *significantly different from TTX (Student’s t test,p < 0.01).

DISCUSSION

Sensory deprivation leads to a decrease in the number of GABA-immunopositive neurons in both somatosensory and visual cortex (Hendry and Jones, 1986; Warren et al., 1989; Kossut et al., 1991;Benevento et al., 1995). This decrease in GABA immunoreactivity appears to be a general response of cortical circuits to a reduction in excitatory drive and suggests that activity levels can regulate the strength of cortical inhibition in both developing and adult animals. In this study, we use an in vitro model system to ask whether activity-dependent changes in GABA expression lead to a functional change in cortical inhibition and to address the mechanism by which this process occurs.

We show that the number of GABA-positive neurons can be decreased in postnatal cortical cultures by blockade of spontaneous activity and that this reduction can be reversed on reinstatement of activity. The magnitude of this effect, an approximate 30% reduction in the number of GABA-positive neurons, is similar to that observed in intact visual cortex after blockade of visual input (Hendry and Jones, 1986;Benevento et al., 1995). Further, we show that the decrease in GABA immunoreactivity can be blocked by BDNF, but not NGF or NT3, and can be mimicked by blockade of Trk receptor signaling with K252a. Finally, we show that the reduction in GABA is correlated with a decrease in the amount and frequency of inhibitory currents onto cortical pyramidal neurons and an increase in pyramidal neuron firing rates. These data suggest that activity continuously adjusts cortical excitability through the BDNF-dependent regulation of inhibition.

All of the effects of activity blockade on our cortical cultures, including the reductions in the number of GABA-immunopositive neurons, the reduction in inhibition, and the increase in pyramidal neuron firing rates, were blocked by co-application of exogenous BDNF. This suggests that activity blockade is exerting these effects through a reduction in endogenous BDNF production. A similar model has been proposed for the activity-dependent regulation of peptide expression in hippocampal interneurons (Marty et al., 1996a). Interestingly, BDNF had no significant effect on any of the parameters measured when activity was intact. BDNF alone did produce a small increase in the frequency of inhibitory currents over control values, but these effects were not statistically significant (Fig. 6), and BDNF alone had no effect on the number of GABA-immunopositive neurons (Fig. 3) or on pyramidal neuron firing rates. The failure of exogenous BDNF to significantly influence these parameters with activity intact suggests that under control conditions, endogenous production of BDNF is close to saturating. If so, then exogenous BDNF would only have an effect under conditions in which endogenous production was reduced, such as activity blockade. Although cortical neuronal cultures are known to express BDNF in an activity-dependent manner, the concentration of this neurotrophin in cortical cultures is unknown (Ghosh et al., 1994).

The effects of BDNF reported here are expressed in the absence of neuronal activity. This is in contrast to several other reported effects of BDNF on cortical neurons, including effects on survival and on dendritic growth (Ghosh et al., 1994; McAllister et al., 1996), although BDNF has been shown to regulate peptide expression in hippocampal interneurons in the absence of spiking activity (Marty et al., 1996b). This suggests that there are heterogeneous mechanisms by which BDNF influences different cortical neuronal properties, some of which require conjoint activity in target neurons and some of which do not. The data reported here show that BDNF regulates inhibition onto cortical pyramidal neurons in the absence of spike generation and spike-mediated synaptic activity. One of the likely functions of this activity-dependent regulation of inhibition is to globally reduce inhibition when activity levels fall too low. To participate in this process, BDNF must be capable of regulating inhibition during periods of absent or very low activity.

BDNF can promote survival of several populations of cultured central neurons, including retinal ganglion cells (Myer-Franke et al., 1995) and largely pure embryonic cortical neurons (Ghosh et al., 1994), as well as some populations of sensory and autonomic neurons (Buj-Bello et al., 1995). In our postnatal cortical cultures, we observed no effect of BDNF on survival over a 2 d period. Additionally, blockade of Trk receptors with K252a for 2 d produced no decrease in neuronal survival. K252a was able to completely block the effects of exogenous BDNF, indicating that it was effectively blocking Trk receptors. K252a is effective at reducing neurotrophin-mediated survival in other systems (Doherty et al., 1989). The failure of K252a to reduce survival in our cultures suggests that under the culture conditions used, in which cortical neurons were co-cultured with cortical astrocytes, survival of postnatal cortical neurons is independent of Trk receptor-mediated signaling pathways. There is evidence that multiple survival signals converge on some populations of central neurons so that dependence on any one factor is not absolute (Myer-Franke et al., 1995).

Several observations suggest that activity blockade is reducing GABA expression within surviving interneurons below our ability to detect rather than reducing interneuronal survival. First, total neuronal survival was not compromised by activity blockade or by any of the manipulations performed in this study. Second, the decrease in GABA-positive neurons was completely reversible. This suggests that a surviving pool of interneurons can be reinduced to express GABA after reinstatement of activity. The alternative possibility is that reversal of activity blockade is inducing a new population of GABAergic neurons to differentiate from a population of neuronal precursor cells present in culture. This is unlikely because cultured embryonic cortical neurons are already postmitotic (Ghosh et al., 1994), and our postnatal cultures are made subsequent to the period of cortical neuronal birth.

The reduction in the number of GABA-positive neurons produced by activity blockade is correlated with a reduction in functional inhibition onto pyramidal neurons. Both the frequency and the magnitude of spontaneous IPSCs were dramatically reduced. An interesting question is whether the change in IPSC frequency is accompanied by a change in the number of synaptic contacts between inhibitory interneurons and pyramidal neurons. Blockade of activity with TTX has been reported to reduce inhibitory synaptogenesis onto cerebellar Purkinje neurons in organotypic cultures (Seil and Drake-Baumann, 1994). An intriguing possibility is that transmitter expression, inhibitory synaptic strength, and the number of synaptic contacts in our cortical cultures are regulated in tandem by ongoing electrical activity.

The decreased inhibition produced by activity blockade is correlated with a dramatic increase in pyramidal neuron firing rates. Consistent with this, electrophysiological recordings from visual cortex of dark-reared rats show an increase in spontaneous activity relative to control animals that correlate with a decrease in the number of GABA-positive neurons (Benevento et al., 1995). In addition, chronic treatments that block spontaneous activity, such as TTX, have been reported to produce hyperexcitability in cortical cultures when washed out, as would be expected for manipulations that reduced inhibition (Ramakers et al., 1990). Activity is known to regulate a number of properties of neurons and circuits, including the expression of conductances that influence intrinsic excitability (Turrigiano et al., 1994, 1995). Although the reduction in inhibition reported here is likely to contribute substantially to the increase in pyramidal neuron firing rates, other factors are also likely to contribute. In addition to reducing inhibition, activity blockade increases the amplitude of miniature excitatory synaptic currents onto pyramidal neurons, suggesting that inhibition and excitation are reciprocally regulated by activity (Turrigiano et al., 1996). Interestingly, BDNF is able to completely prevent the effects of activity blockade on pyramidal neuron firing rates, suggesting that any factors contributing to this change in firing rate are being conjointly regulated by BDNF.

The data we have presented suggest that activity is continuously modulating the amount of inhibition in cortical circuits and that this results in an adjustment in pyramidal neuron firing rates. Our data suggest that this activity-dependent regulation of circuit excitability is mediated through the activity-dependent regulation of BDNF. This in turn suggests that an important function for this neurotrophin is in the control of cortical excitability.

Footnotes